EARLY-BIRD PRICING ENDS IN:
- 00DAYS
- 00HRS
- 00MINS
- 00SECS
Delivered as a Hybrid Event from December 12 - 16, 2021
Live In-Person Experience Delivered December 12 - 16 2021Marriott Marquis San DiegoHans van der Vliet, PhD, MDChief Scientific Officer at Lava Therapeutics BV
Profile
Hans van der Vliet, MD PhD is a medical oncologist and associate professor at the department of medical oncology of the Amsterdam UMC, VU University and Cancer Center Amsterdam and scientific founder and CSO of Lava Therapeutics B.V., a biotech company that develops proprietary Vγ9Vδ2 T-cell engagers.
Agenda Sessions
Bispecific T cell Engagers
9:45amView SessionBispecific γδ-T cell Engagers for Cancer Immunotherapy
On DemandView Session